Validation of the 3D-CAM and the UB-CAM in French
Launched by HOSPICES CIVILS DE LYON · Feb 7, 2022
Trial Information
Current as of May 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults hospitalized in acute geriatric units
- • Aged 65 or older
- • Patient (or relative) not objecting to participating in the study
- Exclusion Criteria:
- • - Legal protection regimes (guardianship, curatorship)
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Villeurbanne, Lyon, France
Patients applied
Trial Officials
Antoine GARNIER-CRUSSARD, MD, MSc
Principal Investigator
Hospices Civils de Lyon
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials